Orange-Peel-Derived Nanobiochar for Targeted Cancer Therapy

Daniela Iannazzo1, Consuelo Celesti1,2, Claudia Espro1

  • 1Department of Engineering, University of Messina, Contrada Di Dio, 98166 Messina, Italy.

Pharmaceutics
|October 27, 2022
PubMed

Insights

Researchers developed a green drug delivery system using nanobiochar from orange peels. Biotin-functionalized nanobiochar effectively delivered drugs to cancer cells, significantly increasing cell death for improved cancer therapy.

Area of Science:

  • Biomaterials Science
  • Nanotechnology
  • Cancer Therapy

Background:

  • Carbon nanostructures offer targeted cancer therapy by recognizing cancer-specific receptors.
  • Developing sustainable and effective nanomaterials for drug delivery is crucial.

Purpose of the Study:

  • To synthesize nanobiochar (NBC) from orange peels via hydrothermal carbonization (HTC) as a cancer-targeting drug delivery platform.
  • To evaluate NBC conjugated with various targeting ligands (biotin, riboflavin, folic acid, hyaluronic acid) for biocompatibility and cancer cell uptake.
  • To assess the anticancer efficacy of drug-loaded NBC systems.

Main Methods:

  • Green synthesis of graphene-like nanobiochar (NBC) from orange peels using hydrothermal carbonization (HTC).
  • Conjugation of NBC with biotin, riboflavin, folic acid, and hyaluronic acid as targeting ligands.
  • In vitro evaluation of biocompatibility and cellular uptake in A549 lung cancer cells.
  • Loading of the poorly water-soluble drug DHF into selected NBC nanosystems and assessment of anticancer activity.

Main Results:

  • Biotin- and riboflavin-conjugated NBC showed the best biocompatibility and uptake in A549 cells.
  • Drug-loaded biotin-functionalized NBC significantly enhanced DHF internalization and anticancer efficacy.
  • Biotin-NBC with DHF more than doubled cancer cell death compared to the drug alone.
  • Oxygen-containing functional groups on NBC improved water dispersion stability for drug delivery.

Conclusions:

  • Green-synthesized nanobiochar from orange peels is a promising nanoplatform for targeted cancer drug delivery.
  • Biotin-functionalized nanobiochar demonstrates superior performance in drug delivery and cancer cell targeting.
  • The presence of oxygen functional groups enhances the stability and effectiveness of nanobiochar-based drug delivery systems.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.0K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K